Portland, OR -- (SBWIRE) -- 09/19/2017 -- Bronchodilators are used in the treatment of obstructive lung diseases by relaxing the lungs muscles and widening the airways (bronchi). They are used in the treatment of asthma and chronic obstructive pulmonary diseases (COPD).
Increase in prevalence of pulmonary disorders, smoking, and junk food fuel the Bronchodilators Market growth. In addition, rise in disposable income, geriatric population, and increase in awareness of healthcare among population are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of the bronchodilators hinder the market. Ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.
Get PDF Brochure of this report: https://www.alliedmarketresearch.com/request-toc-and-sample/3941
The market is segmented on the basis of diseases, drugs type, mode of action, route of administration, devices, and geography. Based on diseases, the market is categorized into asthma, COPD, and others. By drugs type, it is classified into sympathomimetics, anticholinergics, phosphodiesterase inhibitor, and combination drugs.
-The study provides an in-depth analysis of the global bronchodilators market, with current trends and future estimations to elucidate the investment pockets.
-Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
-The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities for the period (20172023) in terms of value.
Early buyers will receive 20% customization on this report